Table 3.
Criterion | Duration of symptoms | Significance (P) | |
---|---|---|---|
≤48 months | >48 months | ||
Age | 39.22 ± 12.39 | 27.78 ± 6.732 | 0.0638* |
Gender (f/m) | 3/8 | 3/1 | 0.7552# |
ICRS score | 3.43 ± 0.53 | 3.62 ± 0.52 | 0.4623* |
Defect size | 3.68 ± 1.34 | 3.97 ± 1.67 | 0.4437* |
KOSS (MRI) | 5.86 ± 1.57 | 8.25 ± 1.98 | 0.0202* |
Henderson score | 2.00 ± 0.82 | 2.87 ± 1.36 | 0.1697* |
Kellgren-Lawrence score | 1.00 ± 0.58 | 0.87 ± 0.83 | 0.7023* |
Duration of symptoms (months) | 23.43 ± 16.36 | 76.50 ± 23.95 | 0.0010* |
Krenn score | 2.00 ± 1.41 | 2.25 ± 1.03 | 0.5048* |
BMP-2-Syn | 2.28 ± 1.89 | 2.37 ± 2.06 | 1.0000* |
BMP-2-C | 2.43 ± 1.90 | 2.25 ± 1.58 | 0.9500* |
BMPR-1A-Syn | 5.00 ± 1.00 | 4.75 ± 0.89 | 0.6171* |
BMPR-1A-C | 2.57 ± 1.62 | 2.62 ± 2.37 | 0.9000* |
Mankin score | 8.00 ± 2.00 | 7.375 ± 3.02 | 0.8590* |
Pritzker score | 3.43 ± 0.79 | 3.62 ± 1.51 | 0.9497* |
*U-Test (Mann-Whitney), #Fisher exact test, f: female, m: male, Syn: synovia, C: cartilage.